Related Experiment Video
Updated: Mar 17, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Dynamic Immune Cell Recruitment After Murine Pulmonary Aspergillus fumigatus Infection under Different
Natarajaswamy Kalleda1, Jorge Amich2, Berkan Arslan3
1Department of Medicine II, Würzburg University HospitalWürzburg, Germany; Research Center for Infectious Diseases, Julius-Maximilians-University WürzburgWürzburg, Germany; Interdisciplinary Center for Clinical Science Research LaboratoryWuürzburg, Germany; Graduate School of Life Sciences WürzburgWürzburg, Germany.
Abstract:
Humans are continuously exposed to airborne spores of the saprophytic fungus Aspergillus fumigatus. However, in healthy individuals pulmonary host defense mechanisms efficiently eliminate the fungus. In contrast, A. fumigatus causes devastating infections in immunocompromised patients. Host immune responses against A. fumigatus lung infections in immunocompromised conditions have remained largely elusive. Given the dynamic changes in immune cell subsets within tissues upon immunosuppressive therapy, we dissected the spatiotemporal pulmonary immune response after A. fumigatus infection to reveal basic immunological events that fail to effectively control invasive fungal disease. In different immunocompromised murine models, myeloid, notably neutrophils, and macrophages, but not lymphoid cells were strongly recruited to the lungs upon infection. Other myeloid cells, particularly dendritic cells and monocytes, were only recruited to lungs of corticosteroid treated mice, which developed a strong pulmonary inflammation after infection. Lymphoid cells, particularly CD4(+) or CD8(+) T-cells and NK cells were highly reduced upon immunosuppression and not recruited after A. fumigatus infection. Moreover, adoptive CD11b(+) myeloid cell transfer rescued cyclophosphamide immunosuppressed mice from lethal A. fumigatus infection but not cortisone and cyclophosphamide immunosuppressed mice. Our findings illustrate that CD11b(+) myeloid cells are critical for anti-A. fumigatus defense under cyclophosphamide immunosuppressed conditions.
Insights
Myeloid cells, particularly neutrophils and macrophages, are crucial for fighting Aspergillus fumigatus lung infections in immunocompromised mice. Transferring these myeloid cells protected mice, highlighting their importance in antifungal defense.
Area of Science:
- Immunology
- Mycology
- Infectious Diseases
Background:
- Humans are exposed to Aspergillus fumigatus spores, but healthy immune systems clear the fungus.
- Immunocompromised individuals are susceptible to invasive A. fumigatus lung infections.
- Immune responses in these patients remain poorly understood.
Purpose of the Study:
- To investigate the spatiotemporal pulmonary immune response to A. fumigatus in immunocompromised models.
- To identify immune mechanisms that fail to control invasive fungal disease.
Main Methods:
- Utilized different immunocompromised murine models.
- Analyzed immune cell recruitment and subsets in the lungs post-infection.
- Performed adoptive transfer of CD11b(+) myeloid cells.
Main Results:
- Myeloid cells (neutrophils, macrophages) were recruited to the lungs.
- Dendritic cells and monocytes were recruited only in corticosteroid-treated mice.
- Lymphoid cells (T-cells, NK cells) were reduced and not recruited.
- Adoptive myeloid cell transfer rescued cyclophosphamide-treated mice but not those treated with cortisone and cyclophosphamide.
Conclusions:
- CD11b(+) myeloid cells are critical for controlling A. fumigatus infections under cyclophosphamide immunosuppression.
- The immune response differs based on the immunosuppressive agent used.
More Related Videos
15:01Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
Published on: September 18, 2021
12:29Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017